Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Binax Inc.

Division of Abbott Laboratories Inc.

Latest From Binax Inc.

Device Venture Financings in 2005

Trends in private device financing in 2005.
Medical Device

Recordati Refocuses

Diversification didn't pay off very well for Italy's Recordati Industria Chimica & Farmaceutica SPA. The company's revised growth strategy depends mostly on developing assets it already has, principally its fine chemicals business, and an already-approved calcium antagonist called lercanidipine.
BioPharmaceutical Strategy

Selling Superiority at BioStar

BioStar has been able to convince doctor's offices that its diagnostic tests are worth more because of their technological superiority. But an FDA clamp-down and stiff competition are forcing BioStar to look for new opportunities and partners.
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Abbott Laboratories Inc.
  • Senior Management
  • Roger Piasio, Pres. & CEO
  • Contact Info
  • Binax Inc.
    Phone: (207) 772-3544
    217 Read St.
    Portland, ME 04103